{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260528130751/en/Landmark-OPTIMA-Trial-Delivers-Practice-Changing-Evidence-that-Veracyte%E2%80%99s-Prosigna-Test-Identifies-Patients-with-High-Risk-Breast-Cancer-Who-Can-Safely-Avoid-Chemotherapy", "message": "News view counter 767715 successfully enlarged"}